Treatment of hepatitis C post treatment can only be determined by your transplant center. Treatment with triple therapy post transplant is experimental and there is no data available to determine how effective treatment is and what percent of patients can even compete treatment post transplant. All information related to your health now that you are a transplant patient should be gotten for the hepatologist at the transplant center that is going to treat your hepatitis C. Each patient is an individual. Only your transplant center can determine the best treatment for your hepatitis C depending on a total medical assessment.
" Is it worth it "
Are you aware the recurrent hepatitis C is probably already damaging your new liver and that is why they are talking about being treated?
What stage liver disease do your know have?
Are you aware that untreated hepatitis C in post transplant patient will rapidly cause liver damage, cirrhosis and liver failure in many transplant patients within 5-10 years post transplant?
They wouldn't want you to treat if you don't already have some stage of fibrosis a;ready occurring occurring.
---------------------------------------------------------------------------------------
What are the possible consequences of HCV infection in liver transplant recipients?
Approximately 20–30% of HCV-infected patients develop cirrhosis within 5 years after transplantation. In contrast, it takes at least 20 years for HCV infection to progress to cirrhosis in nontransplant patients. Many of
the factors mentioned above may contribute to the accelerated
progression observed in the post-transplantation setting. Moreover, transplant recipients who develop cirrhosis decompensate faster and have a higher 5-year mortality rate than HCV-infected cirrhotic patients who
do not undergo transplantation.
Unfortunately, many transplant recipients who develop cirrhosis are not candidates for retransplantation, and outcomes in patients who do undergo retransplantation are usually not good.
What are the typical long-term outcomes when such cases are managed appropriately?
In patients who achieve SVR in response to antiviral treatment, survival rates should be similar to those of transplant recipients who are not HCV-infected. As more clinicians become comfortable using DAA agents
in the post-transplantation setting, we will likely be able to achieve this goal in many more patients.
---------------------------------------------------------------------------------------------
People who are post transplant have very different issues than the 99% of hepatitis C infected patients who have never had a transplant. Post transplant patients require modifications of their immunosuppressants that are beyond the experience and knowledge of pre-transplant patients and most doctors other then liver transplant doctors. Of course close monitoring and avoidance of rejection caused by treatment is also very important.
If you have any questions regarding treatment after transplant here you should post in the "Liver Transplant Expert Forum" where there is a transplant doctor from The Mount Sinai Medical Center that can answer your questions.
http://www.medhelp.org/forums/Liver-Transplant/show/274
Your best source is always your transplant center and all medical procedure done to you should be rub through them first.
Good luck curing your hepatitis C!
Hector